Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients
Authors
Keywords
Corticosteroid tapering, Prostate cancer, Androgen receptor
Journal
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 39, Issue 7, Pages 729-738
Publisher
Springer Nature
Online
2016-01-20
DOI
10.1007/s40618-016-0430-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of on-study corticosteroid use on efficacy and safety in the phase III AFFIRM study of enzalutamide (ENZA), an androgen receptor inhibitor.
- (2017) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Adverse Effects of Androgen Deprivation Therapy: Defining the Problem and Promoting Health Among Men with Prostate Cancer
- (2017) Philip J. Saylor et al. Journal of the National Comprehensive Cancer Network
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular pathways and targets in prostate cancer
- (2015) Emma Shtivelman et al. Oncotarget
- PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
- (2014) AndrewC Hsieh et al. ASIAN JOURNAL OF ANDROLOGY
- Effect of metabolic syndrome and its components on prostate cancer risk: Meta-analysis
- (2014) K. Esposito et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comment gérer l’arrêt d’une corticothérapie ?
- (2014) Jean-Marc Kuhn et al. PRESSE MEDICALE
- Tumor clone dynamics in lethal prostate cancer
- (2014) S. Carreira et al. Science Translational Medicine
- Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer
- (2014) Masis Isikbay et al. Hormones & Cancer
- Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
- (2013) Vivek K. Arora et al. CELL
- Molecular Pathways: Inhibiting Steroid Biosynthesis in Prostate Cancer
- (2013) R. Ferraldeschi et al. CLINICAL CANCER RESEARCH
- Clinical evaluation and optimal management of cancer cachexia
- (2013) Albert Tuca et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- THERAPY OF ENDOCRINE DISEASE: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe
- (2013) Ashley Grossman et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100
- (2012) J. Richards et al. CANCER RESEARCH
- Reduction of insulin signalling pathway IRS-1/IRS-2/AKT/mTOR and decrease of epithelial cell proliferation in the prostate of glucocorticoid-treated rats
- (2012) Maitê M. Costa et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology
- (2012) Norman T Ilowite et al. Pediatric Rheumatology
- Hormonal Therapy Promotes Hormone-Resistant Phenotype by Increasing DNMT Activity and Expression in Prostate Cancer Models
- (2011) Giovanni Luca Gravina et al. ENDOCRINOLOGY
- Clinical and Biochemical Consequences of CYP17A1 Inhibition with Abiraterone Given with and without Exogenous Glucocorticoids in Castrate Men with Advanced Prostate Cancer
- (2011) Gerhardt Attard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
- (2010) Jindan Yu et al. CANCER CELL
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment-Dependent Androgen Receptor Mutations in Prostate Cancer Exploit Multiple Mechanisms to Evade Therapy
- (2009) M. P. Steinkamp et al. CANCER RESEARCH
- Epigenetics in cancer
- (2009) S. Sharma et al. CARCINOGENESIS
- The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline
- (2009) Timothy C. Ryken et al. JOURNAL OF NEURO-ONCOLOGY
- Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate Cancer
- (2008) J. A. Locke et al. CANCER RESEARCH
- Androgen receptor and growth factor signaling cross-talk in prostate cancer cells
- (2008) M.-L. Zhu et al. ENDOCRINE-RELATED CANCER
- Withdrawal from glucocorticosteroid therapy: clinical practice recommendations
- (2008) Crésio Alves et al. Jornal de Pediatria
- The use and toxicity of steroids in the management of patients with brain metastases
- (2008) Alina Sturdza et al. SUPPORTIVE CARE IN CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now